Literature DB >> 1707531

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

D Elias1, T Reshef, O S Birk, R van der Zee, M D Walker, I R Cohen.   

Abstract

Insulin-dependent diabetes mellitus is caused by autoimmune destruction of the insulin-producing beta cells resident in the pancreatic islets. We recently discovered that the pathogenesis of diabetes in NOD strain mice was associated with T-cell reactivity to an antigen cross-reactive with a mycobacterial 65-kDa heat shock protein. To identify peptide epitopes critical to the insulin-dependent diabetes mellitus of NOD mice, we studied the specificities of helper T-cell clones capable of causing hyperglycemia and diabetes. We now report the identification of a functionally important peptide within the sequence of the human variant of the 65-kDa heat shock protein molecule. T-cell clones recognizing this peptide mediate insulitis and hyperglycemia. Alternatively, the T cells can be attenuated and used as therapeutic T-cell vaccines to abort the diabetogenic process. Moreover, administration of the peptide itself to NOD mice can also down-regulate immunity to the 65-kDa heat shock protein and prevent the development of diabetes. Thus, T-cell vaccination and specific peptide therapy are feasible in spontaneous autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707531      PMCID: PMC51390          DOI: 10.1073/pnas.88.8.3088

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Evolution of eye lens crystallins: the stress connection.

Authors:  W W de Jong; W Hendriks; J W Mulders; H Bloemendal
Journal:  Trends Biochem Sci       Date:  1989-09       Impact factor: 13.807

2.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis.

Authors:  W van Eden; J E Thole; R van der Zee; A Noordzij; J D van Embden; E J Hensen; I R Cohen
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

3.  Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.

Authors:  A W Lohse; F Mor; N Karin; I R Cohen
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

4.  Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.

Authors:  O Lider; T Reshef; E Beraud; A Ben-Nun; I R Cohen
Journal:  Science       Date:  1988-01-08       Impact factor: 47.728

5.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

6.  Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

Authors:  D Sun; Y Qin; J Chluba; J T Epplen; H Wekerle
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

7.  Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen.

Authors:  S Jindal; A K Dudani; B Singh; C B Harley; R S Gupta
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.

Authors:  S Baekkeskov; J H Nielsen; B Marner; T Bilde; J Ludvigsson; A Lernmark
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

9.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

Authors:  K Haskins; M Portas; B Bergman; K Lafferty; B Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis.

Authors:  P C Res; C G Schaar; F C Breedveld; W van Eden; J D van Embden; I R Cohen; R R de Vries
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

View more
  90 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  The 60-kDa heat shock protein modulates allograft rejection.

Authors:  O S Birk; S L Gur; D Elias; R Margalit; F Mor; P Carmi; J Bockova; D M Altmann; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanism.

Authors:  X D Yang; J Gasser; U Feige
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 4.  The cellular immune response to heat shock proteins.

Authors:  S H Kaufmann
Journal:  Experientia       Date:  1992-07-15

Review 5.  Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination.

Authors:  A W Lohse; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1992

Review 6.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 7.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

Review 8.  On genetic components in autoimmunity: a critical review based on evolutionarily oriented rationality.

Authors:  J T Epplen
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

Review 9.  The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.

Authors:  Xin Huang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 10.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.